Abiopharma

🔍 HODGSON DAVID C (Director)

Company: Alignment Healthcare, Inc. (ALHC)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 18,982 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 173,408.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents 18,982 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company). The restricted stock units granted to the reporting person are held by him solely for the benefit of General Atlantic Service Company, L.P. The reporting person disclaims beneficial ownership of the restricted stock units and the underlying Common Stock.